Back to top

LACOG | Genitourinary Cancer Group

Representatives

Dr. Diogo Rodrigues Rosa
Chair
Oncoclínicas Group

Dr. Denis Jardim
Scientific Director
Sírio-Libanês Hospital

Dr. Diogo Assed Bastos
Executive Director
ICESP – The Cancer Institute of the State of São Paulo / Sírio-Libanês Hospital

Dr. Karine Trindade
Educational Director
Oncocentro – São Carlos Hospital

Dr. Fábio Kater
Secretary
The Beneficência Portuguesa of São Paulo

LACOG | Genitourinary Cancer Group

Ongoing studies

LACOG 0217 – IRONMAN | Prostate Cancer Outcomes: An International Registry to Improve Outcomes in Men with Advanced Prostate Cancer 

 

LACOG 0218 – Hercules | A phase II trial of pembrolizumab combined with cisplatin-based chemotherapy as first-line systemic therapy in advanced penile cancer

 

LACOG 0415 – APA in Prostate Cancer | Phase II randomized study of Abiraterone acetate plus ADT versus APALUTAMIDE versus Abiraterone and APALUTAMIDE in patients with advanced prostate cancer with non-castrate testosterone levels

 

LACOG 0515 – Testicular Registry | Multicentric database of patients with germ cell tumor with the purpose of clinical and pathological characterization and evaluation of cancer treatment outcomes

 

LACOG 0519 – PEACE III | A Randomized multicenter phase III trial comparing enzalutamide vs. a combination of Ra223 and enzalutamide in asymptomatic or mildly symptomatic castration resistant prostate cancer patients metastatic to bone. PEACE III

 

LACOG 0620 – ExBAT | Extreme Bipolar Androgen Therapy with Darolutamide and Testosterone Cypionate in Patients with Metastatic Castration-Resistant Prostate Cancer (ExBAT trial)

 

LACOG 1120 – RENAL REGISTRY | Clinicopathological characteristics and outcomes of patients with Renal Cell Carcinoma in Latin America

 

LACOG 1518 – Bladder Cancer Registry | Clinical-pathological Characterization and Outcomes of Metastatic Urothelial Cancer in Latin America: Retrospective and Translational Multicenter Database

 

LACOG 1818 – Prostate Cancer Registry | Survival outcomes in metastatic prostate cancer in the Brazilian population – analysis of individual characteristics and treatment modalities in different national health institutions